) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 1.3%. By the end of trading, Regeneron Pharmaceuticals fell $2.39 (-2.1%) to $113.70 on light volume. Throughout the day, 549,112 shares of Regeneron Pharmaceuticals exchanged hands as compared to its average daily volume of one million shares. The stock ranged in price between $112.57-$116.52 after having opened the day at $114.93 as compared to the previous trading day's close of $116.09. Other company's within the Health Care sector that declined today were:
), down 20%,
), down 17.4%,
), down 12%, and
), down 11.9%.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of serious medical conditions in the United States. Regeneron Pharmaceuticals has a market cap of $10.6 billion and is part of the
industry. Shares are up 109.4% year to date as of the close of trading on Tuesday. Currently there are nine analysts that rate Regeneron Pharmaceuticals a buy, no analysts rate it a sell, and five rate it a hold.
TheStreet Ratings rates Regeneron Pharmaceuticals as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and poor profit margins.
- You can view the full Regeneron Ratings Report.
On the positive front,
), up 34.9%,
), up 28.7%,
), up 23.4%, and
), up 21.5%, were all gainers within the health care sector with
) being today's featured health care sector winner.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
) while those bearish on the health care sector could consider
- Find other investment ideas from our top rated ETFs lists.